Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor
Go back to Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor| Pfizer Inc. (NYSE: PFE) | Delayed: 28.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.72 | 52 Week High | $37.39 | |||
| Open | $28.72 | 52 Week Low | $28.25 | |||
| Day High | $28.72 | P/E | 17.41 | |||
| Day Low | $28.72 | EPS | $1.65 | |||
| Volume | 159,408 | |||||
